Effective December 1, 2025, State Street Investment Management is the distributor for the Select Sector SPDR® ETFs. No changes are being made to the funds' investment objective or investment strategy. Learn more.

As of December 5, 2025, forward stock splits on five Select Sector SPDR® Funds will go into effect, increasing number of shares outstanding and decreasing the Funds’ share price. The aggregate market value of shares outstanding will not be impacted. Click here for more information.

XLV State Street® Health Care Select Sector SPDR® ETF

Morningstar Fund Comparison

Important Risk Disclosure

In general, ETFs can be expected to move up or down in value with the value of the applicable index. Although ETF shares may be bought and sold on the exchange through any brokerage account, ETF shares are not individually redeemable from the Fund. Investors may acquire ETFs and tender them for redemption through the Fund in Creation Unit Aggregations only. Please see the prospectus for more details.

Equity securities may fluctuate in value and can decline significantly in response to the activities of individual companies and general market and economic conditions.

All ETFs are subject to risk, including possible loss of principal. Sector ETF products are also subject to sector risk and non-diversification risk, which generally result in greater price fluctuations than the overall market.

Select Sector SPDR Funds bear a higher level of risk than more broadly diversified funds.

Non-diversified funds that focus on a relatively small number of securities tend to be more volatile than diversified funds and the market as a whole.

Passively managed funds invest by sampling the index, holding a range of securities that, in the aggregate, approximates the full Index in terms of key risk factors and other characteristics. This may cause the fund to experience tracking errors relative to performance of the index.

While the shares of ETFs are tradable on secondary markets, they may not readily trade in all market conditions and may trade at significant discounts in periods of market stress.

ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

Intellectual Property Information: The S&P 500^® Index is a product of S&P Dow Jones Indices LLC or its affiliates (“S&P DJI”) and have been licensed for use by State Street Global Advisors. S&P^®, SPDR^®, S&P 500^®,US 500 and the 500 are trademarks of Standard & Poor’s Financial Services LLC (“S&P”); Dow Jones^® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”) and has been licensed for use by S&P Dow Jones Indices; and these trademarks have been licensed for use by S&P DJI and sublicensed for certain purposes by State Street Global Advisors. The fund is not sponsored, endorsed, sold or promoted by S&P DJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of these indices.

Before investing, consider the funds' investment objectives, risks, charges and expenses. To obtain a prospectus or summary prospectus which contains this and other information, call 1-866-787-2257 download a prospectus or summary prospectus now, or talk to your financial advisor. Read it carefully before investing.

The Fund's investments are subject to changes in general economic conditions, general market fluctuations and the risks inherent in investment in securities markets. Investment markets can be volatile and prices of investments can change substantially due to various factors including, but not limited to, economic growth or recession, changes in interest rates, changes in the actual or perceived creditworthiness of issuers, and general market liquidity. The Fund is subject to the risk that geopolitical events will disrupt securities markets and adversely affect global economies and markets. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, or other events could have a significant impact on the Fund and its investments.

Overview Performance Holdings Documents Purchase Information More Insights

Morningstar Fund Comparison

NAV

NAV

The market value of a mutual fund's or ETFs total assets, minus liabilities, divided by the number of shares outstanding.

$153.94

as of Dec 04 2025

Base Currency

USD

Assets Under Management

$40,295.71 M

as of Dec 04 2025

Gross Expense Ratio

Gross Expense Ratio

The fund's total annual operating expense ratio. It is gross of any fee waivers or expense reimbursements. It can be found in the fund's most recent prospectus.

0.08%

Overall Morningstar Rating

as of Oct 31 2025

Quick Links

Key Features

The State Street^® Health Care Select Sector SPDR^® ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index (the "Index").
The Index seeks to provide an effective representation of the health care sector of the S&P 500 Index.
Seeks to provide precise exposure to companies in the pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology industries.
Allows investors to take strategic or tactical positions at a more targeted level than traditional style based investing.

About this Benchmark

The companies included in each Select Sector Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor’s 500 Composite Stock^® Index (“S&P 500^®”). The eleven Select Sector Indexes (each a “Select Sector Index”) upon which the Select Sector SPDR Funds are based together comprise all of the companies in the S&P 500.

The Health Care Select Sector Index includes companies from the following industries: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology.

Fund Information as of Dec 05 2025

Benchmark	Health Care Select Sector Index
Inception Date	Dec 16 1998
Options Available	Yes
Gross Expense Ratio Gross Expense Ratio The fund's total annual operating expense ratio. It is gross of any fee waivers or expense reimbursements. It can be found in the fund's most recent prospectus.	0.08%
Base Currency	USD
Administrator	State Street Global Advisors Funds Management Inc.
Investment Manager	SSGA Funds Management, Inc.
Management Team	Systematic Equity Beta Group
Distributor	State Street Global Advisors Funds Distributors, LLC
Distribution Frequency	Quarterly

Listing Information as of Dec 05 2025

Exchange	Listing Date	Trading Currency	Ticker	CUSIP	ISIN
NYSE ARCA	Dec 22 1998	USD	XLV	81369Y209	US81369Y2090

Fund Characteristics as of Dec 04 2025

Est. 3-5 Year EPS Growth Estimated 3-5 Year EPS Growth Based on the underlying holdings of the fund. The actual earnings estimates for the underlying holdings are provided by FactSet Estimates and are used to calculate a mean 3-5 year EPS growth rate estimate.	9.41%
Number of Holdings	60
Price/Book Ratio Price/Book Ratio The weighted harmonic average of closing market price divided by the most recent reported book value for each security in the fund's portfolio as calculated for the last twelve months.	4.42
Price/Earnings Ratio FY1 Price/Earnings Ratio FY1 The weighted harmonic average of current share price divided by the forecasted one year earnings per share for each security in the fund. Negative and positive outliers are included in the calculation.	19.46
Weighted Average Market Cap	$302,097.97 M

Index Characteristics as of Dec 04 2025

Est. 3-5 Year EPS Growth	9.41%
Number of Holdings	60
Price/Cash Flow	18.93
Price/Earnings	26.52
Price/Earnings Ratio FY1	19.46

Index Statistics as of Dec 04 2025

Weighted Average Market Cap	Mean	Median	Largest	Smallest
	Average Size		Size Range
$302,097.47 M	$95,769.40 M	$40,143.22 M	$908,821.75 M	$7,679.07 M

Yields as of Dec 03 2025

30 Day SEC Yield 30 Day SEC Yield (Also known as Standardized Yield) An annualized yield that is calculated by dividing the net investment income earned by the fund over the most recent 30-day period by the maximum offering price on the last day of the period.	1.58%
30 Day SEC Yield (Unsubsidized) 30 Day SEC Yield (Unsubsidized) An annualized yield that is calculated by dividing the net investment income earned by the fund over the most recent 30-day period by the current maximum offering price that does not account for expense ratio waivers.	-
Fund Distribution Yield Fund Distribution Yield The sum of the distributions within the past 365 days divided by Net Asset Value per share, expressed as a percentage.	1.57%
Index Dividend Yield Index Dividend Yield The weighted average of the underlyings' indicated annual dividend divided by price, expressed as a percentage.	1.66%

Fund Market Price as of Dec 04 2025

Bid/Ask Bid/Ask Mid Point (Also known as Mid Price) The price between the best price of the sellers for a trading unit of a given security and the best price of the buyer of a trading unit of a given security.	$153.92
Closing Price Closing Price Market Price of last reported trade on the exchange.	$153.90
Day High	$155.02
Day Low	$153.38
Exchange Volume (Shares) Exchange Volume (shares) Represents the volume of shares traded on the ETF's primary exchange throughout the previous business day.	4,392,827
Premium/Discount Premium/Discount to NAV Shows the comparison of the daily net asset value (NAV) and the Midpoint of the closing bid/ask for each of the funds calculated as ((4PM Bid/Ask - Closing NAV) / Closing NAV * 100)	-0.01%
30-Day Median Bid/Ask Spread The median bid-ask spread is calculated by identifying national best bid and national best offer ("NBBO") for each Fund as of the end of each 10 second interval during each trading day of the last 30 calendar days and dividing the difference between each such bid and offer by the midpoint of the NBBO. The median of those values is identified and posted on each business day.	0.01%

Premium Discount to NAV Graph and Summary

The line graph and table below show historical information about the differences between the daily closing price for shares of the fund (as determined by the fund’s listing exchange) and the fund’s net asset value over certain periods. The vertical axis of the line graph shows the premium/discount expressed as a percentage of NAV. The horizontal axis indicates the date at which the premium/discount occurred. The table shows the number of trading days in which the fund traded at a premium or at a discount to NAV.

Number of Days Summary

	Calendar Year 2024	First Quarter of 2025	Second Quarter of 2025	Third Quarter of 2025
Days Traded at Premium Number of days the ETF 4PM Bid/Ask was above the NAV.	135	29	27	33
Days Traded at Discount Number of days the ETF 4PM Bid/Ask was below the NAV.	116	31	35	31

Fund Data

Because ETFs trade like stocks at current market prices, shareholders may pay more than a fund’s NAV when purchasing fund shares and may receive less than a fund’s NAV when selling fund shares.

Fund Net Cash Amount as of Dec 04 2025

Net Cash Amount

$88,142,698.01

Fund Net Asset Value as of Dec 04 2025

NAV NAV The market value of a mutual fund's or ETFs total assets, minus liabilities, divided by the number of shares outstanding.	$153.94
Shares Outstanding	261.77 M
Assets Under Management	$40,295.71 M

Most Recent NAV / NAV History

Morningstar Rating as of Oct 31 2025

Category	Rating Overall Month End	Rating 3 Year Month End	Rating 5 Year Month End	Rating 10 Year Month End
Health	★★★★★	★★★	★★★★★	★★★★★
# of Funds in Category	-	165	152	118

Morningstar Rating

The Morningstar Rating for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange- traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The Morningstar Rating does not include any adjustment for sales loads. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/ 40% three-year rating for 60-119 months of total returns, and 50% 10- year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10- year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.

Morningstar Return

The Morningstar Return rates a managed investment’s performance relative to other managed products in its Morningstar Category. It is an assessment of a product's excess return over a risk-free rate (the return of the 90- day Treasury Bill) in comparison with the products in its Morningstar category. In each Morningstar category, the top 10% of products earn a High Morningstar Return (High), the next 22.5% Above Average (+Avg), the middle 35% Average (Avg), the next 22.5% Below Average (-Ave), and the bottom 10% Low (Low). Morningstar Return is measured for up to three time periods (three, five, and 10 years). These separate measures are then weighted and averaged to produce an overall measure for the product. Products with less than three years of performance history are not rated.

Morningstar Risk

Morningstar Risk evaluates a managed investment’s downside volatility relative to that of other products in its Morningstar Category. It is an assessment of the variations in monthly returns, with an emphasis on downside variations, in comparison with the products in its Morningstar category. In each Morningstar category, the 10% of products with the lowest measured risk are described as Low Risk (Low), the next 22.5% Below Average (-Avg), the middle 35% Average (Avg), the next 22.5% Above Average (+Avg), and the top 10% High (High). Morningstar Risk is measured for up to three time periods (three, five, and 10 years). These separate measures are then weighted and averaged to produce an overall measure for the product. Products with less than three years of performance history are not rated.

© 2025 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Fund Performance

Fund Inception Date: Dec 16 1998

as of Oct 31 2025

	As Of	1 Month	QTD	YTD	1 Year	3 Year	5 Year	10 Year	Since Inception Dec 16 1998
Fund Before Tax
NAV	Oct 31 2025	3.57%	3.57%	6.23%	-0.09%	4.51%	8.95%	9.08%	8.47%
Market Value	Oct 31 2025	3.62%	3.62%	6.21%	-0.05%	4.52%	8.94%	9.08%	8.48%
Benchmark Health Care Select Sector Index	Oct 31 2025	3.58%	3.58%	6.29%	-0.03%	4.59%	9.07%	9.21%	8.68%
Fund After Tax
Return after Taxes on Distributions	Oct 31 2025	3.57%	3.57%	5.66%	-0.73%	4.02%	8.50%	8.61%	8.13%
Return after Taxes on Distributions and Sale of Fund Shares	Oct 31 2025	2.11%	2.11%	3.67%	0.00%	3.37%	6.99%	7.32%	7.34%
Benchmark Health Care Select Sector Index	Oct 31 2025	3.58%	3.58%	6.29%	-0.03%	4.59%	9.07%	9.21%	8.68%

as of Sep 30 2025

	As Of	1 Month	QTD	YTD	1 Year	3 Year	5 Year	10 Year	Since Inception Dec 16 1998
Fund Before Tax
NAV	Sep 30 2025	1.78%	3.75%	2.57%	-7.99%	6.53%	7.38%	9.50%	8.36%
Market Value	Sep 30 2025	1.73%	3.75%	2.50%	-8.01%	6.49%	7.40%	9.51%	8.36%
Benchmark Health Care Select Sector Index	Sep 30 2025	1.78%	3.76%	2.61%	-7.95%	6.61%	7.49%	9.64%	8.57%
Fund After Tax
Return after Taxes on Distributions	Sep 30 2025	1.59%	3.55%	2.02%	-8.58%	6.03%	6.93%	9.04%	8.02%
Return after Taxes on Distributions and Sale of Fund Shares	Sep 30 2025	1.05%	2.22%	1.51%	-4.67%	4.95%	5.73%	7.70%	7.24%
Benchmark Health Care Select Sector Index	Sep 30 2025	1.78%	3.76%	2.61%	-7.95%	6.61%	7.49%	9.64%	8.57%

Past performance is not a reliable indicator of future performance. Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold. Current performance may be higher or lower than that quoted. Performance of an index is not illustrative of any particular investment. All results are historical and assume the reinvestment of dividends and capital gains. It is not possible to invest directly in an index.

Performance returns for periods of less than one year are not annualized. Performance is shown net of fees.

Index returns are unmanaged and do not reflect the deduction of any fees or expenses. Index returns reflect all items of income, gain and loss and the reinvestment of dividends and other income as applicable.

The market price used to calculate the Market Value return is the midpoint between the highest bid and the lowest offer on the exchange on which the shares of the Fund are listed for trading, as of the time that the Fund's NAV is calculated. If you trade your shares at another time, your return may differ.

Gross Expense Ratio: 0.08%

Top Holdings

Subject to change.

as of Dec 04 2025

Fund Top Holdings as of Dec 04 2025

Name	Shares Held	Weight
ELI LILLY + CO	5,733,748	14.44%
JOHNSON + JOHNSON	17,368,928	8.73%
ABBVIE INC	12,740,402	7.23%
UNITEDHEALTH GROUP INC	6,531,773	5.41%
MERCK + CO. INC.	18,014,015	4.51%
ABBOTT LABORATORIES	12,552,245	3.91%
THERMO FISHER SCIENTIFIC INC	2,723,316	3.89%
INTUITIVE SURGICAL INC	2,585,322	3.65%
AMGEN INC	3,882,658	3.28%
GILEAD SCIENCES INC	8,948,679	2.72%

Download All Holdings: Daily

Index Top Holdings as of Dec 04 2025

Name	Weight
Eli Lilly and Company	14.47%
Johnson & Johnson	8.75%
AbbVie Inc.	7.25%
UnitedHealth Group Incorporated	5.42%
Merck & Co. Inc.	4.52%
Abbott Laboratories	3.92%
Thermo Fisher Scientific Inc.	3.90%
Intuitive Surgical Inc.	3.66%
Amgen Inc.	3.29%
Gilead Sciences Inc.	2.73%

Industry Allocation

as of Dec 04 2025

Fund Industry Allocation as of Dec 04 2025

Sector	Weight
Pharmaceuticals	33.44%
Health Care Equipment & Supplies	21.84%
Biotechnology	17.62%
Health Care Providers & Services	17.30%
Life Sciences Tools & Services	9.80%

Index Industry Allocation as of Dec 04 2025

Sector	Weight
Pharmaceuticals	33.44%
Health Care Equipment & Supplies	21.84%
Biotechnology	17.62%
Health Care Providers & Services	17.30%
Life Sciences Tools & Services	9.80%

Document

Fund Documents

Tax Documents

Information & Schedules

Insights & Resources

Sector Business Cycle Analysis pdf

Purchase Information

Buying and Selling ETFs

ETFs are flexible and easy to trade. Investors buy and sell them like stocks, typically through a brokerage account. Investors can also employ traditional stock trading techniques; including stop orders, limit orders, margin purchases, and short sales using ETFs. They are listed on major US Stock Exchanges.

ETFs are subject to risk similar to those of stocks including those regarding short-selling and margin account maintenance.

Ordinary brokerage commissions apply.

There are no sales loads on Select Sector SPDR shares but ordinary brokerage commissions apply and this expense is not reflected in performance calculations.

After-tax returns are calculated based on NAV using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor's tax situation and may differ from those shown. The after-tax returns shown are not relevant to investors who hold their fund shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts.

Unless Otherwise noted all information contained herein is that of the State Street^® Health Care Select Sector SPDR^® ETF.

Performance of an index is not illustrative of any particular investment. It is not possible to invest directly in an index.

Holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future.

As with all stocks, you may be required to deposit more money or securities into your margin account if the equity, including the amount attributable to your ETF shares, declines.

All total return figures assume reinvestment of dividend and capital gains at net assets value; actual returns may differ.

XLV State Street® Health Care Select Sector SPDR® ETF

Key Features

About this Benchmark

Fund Information as of Dec 05 2025

Listing Information as of Dec 05 2025

Fund Characteristics as of Dec 04 2025

Index Characteristics as of Dec 04 2025

Index Statistics as of Dec 04 2025

Yields as of Dec 03 2025

Fund Market Price as of Dec 04 2025

Number of Days Summary

Fund Net Cash Amount as of Dec 04 2025

Fund Net Asset Value as of Dec 04 2025

Morningstar Rating as of Oct 31 2025

Fund Performance

Top Holdings Subject to change.

Fund Top Holdings as of Dec 04 2025

Index Top Holdings as of Dec 04 2025

Industry Allocation

Fund Industry Allocation as of Dec 04 2025

Index Industry Allocation as of Dec 04 2025

Document

Purchase Information

Top Holdings

Subject to change.